China Dasheng Biotechnology Company
CDBTOTCFinancial Services
$0.10
+$0.00(+0.00%)
Market Cap$4097600
P/E Ratio—
52W High$0.15
52W Low$0.0003
China Dasheng Biotechnology Company (CDBT) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CDBT · earnings · updated Jun 9, 2026
Latest Earnings
Q1 FY2009Report Date: Mar 31, 2009EPS Actual
$0.04
Revenue
$0.01B
Fiscal Period
Q1 FY2009
FY ends December
Report Date
Mar 31, 2009
After Market Close
CDBT reports quarterly as a OTC-listed Shell Companies company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q1 FY2009 | Mar 31, 2009 | — | $0.04 | — | $0.01B | — | — |
| — Q4 FY2008 | Dec 31, 2008 | — | $0.06 | — | $0.01B | — | — |
| — Q3 FY2008 | Sep 30, 2008 | — | $0.04 | — | $0.01B | — | — |
| — Q1 FY2008 | Mar 31, 2008 | — | $0.01 | — | $0.00B | — | — |
| — Q4 FY2007 | Dec 31, 2007 | — | $0.05 | — | $0.00B | — | — |
| — Q3 FY2007 | Jul 31, 2007 | — | -$0.00 | — | $0.00B | — | — |
| — Q2 FY2007 | Apr 30, 2007 | — | -$0.00 | — | $0.00B | — | — |
| — Q1 FY2007 | Jan 31, 2007 | — | -$0.00 | — | $0.00B | — | — |
Q1 FY2009
Mar 31, 2009
EPS Actual
$0.04
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q4 FY2008
Dec 31, 2008
EPS Actual
$0.06
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q3 FY2008
Sep 30, 2008
EPS Actual
$0.04
EPS Est.
—
EPS Surpr.
—
Revenue
$0.01B
Q1 FY2008
Mar 31, 2008
EPS Actual
$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q4 FY2007
Dec 31, 2007
EPS Actual
$0.05
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q3 FY2007
Jul 31, 2007
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q2 FY2007
Apr 30, 2007
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Q1 FY2007
Jan 31, 2007
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2024 | $1.54 | $1.54 | $1.54 | 1 |
| Q2 FY2024 | $1.34 | $1.34 | $1.34 | 1 |
| Q1 FY2024 | $1.58 | $1.58 | $1.58 | 1 |
| Q4 FY2023 | $2.09 | $2.09 | $2.09 | 1 |
| Q3 FY2023 | $1.39 | $1.39 | $1.39 | 1 |
| Q2 FY2023 | $1.19 | $1.19 | $1.19 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2023 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2023 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2023 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q1 FY2009 | Mar 31, 2009 | — | $0.70 | $1.00 | +42.86% |
| — Q4 FY2008 | Dec 31, 2008 | — | $1.50 | $1.50 | +0.00% |
| — Q3 FY2008 | Sep 30, 2008 | — | $1.95 | $1.95 | +0.00% |
| — Q1 FY2008 | Mar 31, 2008 | — | $2.10 | $2.10 | +0.00% |
| — Q4 FY2007 | Dec 31, 2007 | — | No price data | $2.00 | — |
| — Q3 FY2007 | Jul 31, 2007 | — | No price data | $2.00 | — |
| — Q2 FY2007 | Apr 30, 2007 | — | No price data | $2.00 | — |
| — Q1 FY2007 | Jan 31, 2007 | — | No price data | $2.00 | — |
Q1 FY2009+42.86%
Report Date
Mar 31, 2009
EPS Beat/Miss
—
Price Before
$0.70
Price After
$1.00
Q4 FY2008+0.00%
Report Date
Dec 31, 2008
EPS Beat/Miss
—
Price Before
$1.50
Price After
$1.50
Q3 FY2008+0.00%
Report Date
Sep 30, 2008
EPS Beat/Miss
—
Price Before
$1.95
Price After
$1.95
Q1 FY2008+0.00%
Report Date
Mar 31, 2008
EPS Beat/Miss
—
Price Before
$2.10
Price After
$2.10
Q4 FY2007—
Report Date
Dec 31, 2007
EPS Beat/Miss
—
Price Before
—
Price After
$2.00
Q3 FY2007—
Report Date
Jul 31, 2007
EPS Beat/Miss
—
Price Before
—
Price After
$2.00
Q2 FY2007—
Report Date
Apr 30, 2007
EPS Beat/Miss
—
Price Before
—
Price After
$2.00
Q1 FY2007—
Report Date
Jan 31, 2007
EPS Beat/Miss
—
Price Before
—
Price After
$2.00
Beat Rate0 / 8 quarters
Largest Move+42.86% (Q1 FY2009)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CDBT ends December
China Dasheng Biotechnology Company (CDBT) most recently reported earnings on March 31, 2009 for Q1 FY2009, posting EPS of $0.04 (in line with the analyst consensus of —). The next CDBT earnings date is expected around September 1, 2026.
Each quarter, investors track CDBT earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CDBT revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CDBT's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CDBT earnings · 4 questionsChina Dasheng Biotechnology Company's next earnings report is expected around September 1, 2026. CDBT typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CDBT historically reports after market close (AMC).
CDBT earnings datewhen is CDBT earningsCDBT next earnings datewhen does CDBT report earningsCDBT earnings calendar
▸ Source: FMP · China Dasheng Biotechnology Company SEC filings · US GAAP · China Dasheng Biotechnology Company SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026